With Jeffrey Jaeckel
Yesterday, the U.S. Federal Trade Commission ("FTC") issued its final rule (the "New Rule") to the Hart-Scott-Rodino ("HSR") Act Premerger Notification Regulations to clarify and expand the coverage of the HSR Act to patent license and collaboration agreements in the pharmaceuticals industry where the licensee acquires "all commercially significant rights" to the pharmaceutical patents.